24/7 Patient Assistance: 760-405-8205

Robert A. Figlin, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Robert Figlin is a specialist in medical oncology based in Los Angeles, California and he is affiliated with many regional hospitals, like Cedars-Sinai Medical Center and UCLA Medical Center. He graduated from Medical College of Pennsylvania where he got his medical degree. He did his residency program in internal medicine at Cedars-Sinai Medical Center. He did a fellowship in hematology at UCLA Medical Center. The doctor is board certified in internal medicine and medical oncology and he has been practicing for more than 20 years.

  • Education & Training


    Medical College of Pennsylvania

    Medical School


    Cedars-Sinai Medical Center



    UCLA Medical Center


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Cedars-Sinai Medical Center

    Languages: English/Spanish

    (310) 423-3277

    8700 Beverly Blvd

    Los Angeles, California 90048

    Read More

    Ronald Reagan UCLA Medical Center

    Languages: English/Spanish

    (310) 825-9111

    757 Westwood Plaza

    Los Angeles, California 90095

    Read More
  • Publications & Memberships

    Dr. Robert A. Figlin has contributed to 3 publications.

    The value of surrogate endpoints for predicting real-world survival across five cancer types.

    Shafrin, J.,Brookmeyer, R.,Peneva, D.,Park, J.,Zhang, J.,Figlin, R. A.,Lakdawalla, D. N.; Curr Med Res Opin. 2016 Jan 09.

    See more >>

    Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer.

    Pal, S. K.,Vuong, W.,Zhang, W.,Deng, J.,Liu, X.,Carmichael, C.,Ruel, N.,Pinnamaneni, M.,Twardowski, P.,Lau, C.,Yu, H.,Figlin, R. A.,Agarwal, N.,Jones, J. O.; Mol. Cancer Ther.. 2015 Oct 10.

    See more >>

    The High-Dose Aldesleukin "Select" Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma.

    McDermott, D. F.,Cheng, S. C.,Signoretti, S.,Margolin, K. A.,Clark, J. I.,Sosman, J. A.,Dutcher, J. P.,Logan, T. F.,Curti, B. D.,Ernstoff, M. S.,Appleman, L.,Wong, M. ...; Clin. Cancer Res.. 2014 Nov 27.

    See more >>


    American Society of Clinical Oncology